Zymtronix: Funding, Investors & Team (Oct 2026)
Zymtronix develops technology for enzyme immobilization. It provides a platform to immobilize enzymes and screen for immobilized enzyme performance, the unlocked potential of oxidative enzymes for biocatalysis, and new materials and customer-oriented processes for small molecule conversion. The company is optimizing enzyme immobilization to create unique, and sustainable and responsible processes for high-performance biocatalysis. Stéphane Corgié founded Zymtronix in 2013. It has its headquarters in Ithaca in New York.
Zymtronix has raised $2.0M across 1 funding round on record, the most recent a Debt Financing of $2.0M announced in Dec 2021.
That round is below the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Zymtronix Company Profile and Key Stats
Latest funding round on record: Dec 2021.
Zymtronix Funding Rounds
Zymtronix Founders and Leadership Team
No contact details are on record for this team yet.
Zymtronix Funding Compared to Other Biotechnology Startups
Zymtronix's latest round of $2.0M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Zymtronix in Biotechnology and Ithaca
Companies Similar to Zymtronix
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Circle Pharma is a biotechnology company in the initial stages of development that uses unique computational…
Evvy is for people with vaginas who want to be empowered with information about their microbiome. Their…
Zymtronix Funding FAQs
What does Zymtronix do?
Zymtronix develops technology for enzyme immobilization. It provides a platform to immobilize enzymes and screen for immobilized enzyme performance, the unlocked potential of oxidative enzymes for biocatalysis, and new materials and customer-oriented processes for small molecule conversion. The company is optimizing enzyme immobilization to create unique, and sustainable and responsible processes for high-performance biocatalysis. Stéphane Corgié founded Zymtronix in 2013. It has its headquarters in Ithaca in New York.
How much funding has Zymtronix raised?
Zymtronix has raised $2.0M across 1 round on record. The most recent is a Debt Financing of $2.0M announced in Dec 2021.
When did Zymtronix last raise funding?
Zymtronix's most recent funding round on record is a Debt Financing of $2.0M, announced in Dec 2021.
Who is the CEO of Zymtronix?
Stéphane Corgie is listed as CEO at Zymtronix.
Where is Zymtronix headquartered?
Zymtronix is based in Ithaca, New York, United States.
How many employees does Zymtronix have?
Zymtronix is in the 11-50 employee band.
How does Zymtronix's funding compare to other Biotechnology startups?
Zymtronix's latest round of $2.0M is below the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Zymtronix Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Zymtronix is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.